Intermittent fasting & performance: The iFast clinical trial protocol
There is increasing evidence from animal and human studies suggesting that fasting can play a role in disease prevention, weight control and longevity. However, few studies have compared exercise performances in individuals adhering to an intermittent fasting (IF) in comparison to individuals who ar...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-02-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865421000673 |
_version_ | 1798016018210095104 |
---|---|
author | Abbass El-Outa Lara Ghandour Hani Hamade Cecile Borgi Elie-Jacques Fares Tarek Gherbal Afif Mufarrij |
author_facet | Abbass El-Outa Lara Ghandour Hani Hamade Cecile Borgi Elie-Jacques Fares Tarek Gherbal Afif Mufarrij |
author_sort | Abbass El-Outa |
collection | DOAJ |
description | There is increasing evidence from animal and human studies suggesting that fasting can play a role in disease prevention, weight control and longevity. However, few studies have compared exercise performances in individuals adhering to an intermittent fasting (IF) in comparison to individuals who are not. Given the rising popularity of IF we aim to investigate whether this type eating pattern will improve cardiovascular performance over a period of 12 weeks through VO2 max measurements in participants from a Lebanese community. Additionally, we will study the variation of different health parameters, physical performance and biomarkers potentially affected by IF. Participants will be recruited from a large university community and randomized into 4 arms. Baseline information will be collected from all participants, which includes biological, physical, nutritional, medical and psychological data. Two arms will follow a time-restricted fasting diet with and without physical exercise, one arm will exercise without fasting, and one will act as a control group. Throughout the study, measurements will be repeated, and data analysis will follow to evaluate results. |
first_indexed | 2024-04-11T15:43:59Z |
format | Article |
id | doaj.art-c03efa01e08c43f6b69e2b933fc40cbb |
institution | Directory Open Access Journal |
issn | 2451-8654 |
language | English |
last_indexed | 2024-04-11T15:43:59Z |
publishDate | 2022-02-01 |
publisher | Elsevier |
record_format | Article |
series | Contemporary Clinical Trials Communications |
spelling | doaj.art-c03efa01e08c43f6b69e2b933fc40cbb2022-12-22T04:15:40ZengElsevierContemporary Clinical Trials Communications2451-86542022-02-0125100766Intermittent fasting & performance: The iFast clinical trial protocolAbbass El-Outa0Lara Ghandour1Hani Hamade2Cecile Borgi3Elie-Jacques Fares4Tarek Gherbal5Afif Mufarrij6Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Internal Medicine, The MetroHealth System, Cleveland, USADepartment of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, LebanonDepartment of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, LebanonUniversity Sports, Office of Student Affairs, American University of Beirut, Beirut, LebanonDepartment of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Corresponding author. Department of Emergency Medicine, American University of Beirut Medical Center, P.O.Box - 11-0236 Riad El Solh, Beirut, 1107 2020, Lebanon.There is increasing evidence from animal and human studies suggesting that fasting can play a role in disease prevention, weight control and longevity. However, few studies have compared exercise performances in individuals adhering to an intermittent fasting (IF) in comparison to individuals who are not. Given the rising popularity of IF we aim to investigate whether this type eating pattern will improve cardiovascular performance over a period of 12 weeks through VO2 max measurements in participants from a Lebanese community. Additionally, we will study the variation of different health parameters, physical performance and biomarkers potentially affected by IF. Participants will be recruited from a large university community and randomized into 4 arms. Baseline information will be collected from all participants, which includes biological, physical, nutritional, medical and psychological data. Two arms will follow a time-restricted fasting diet with and without physical exercise, one arm will exercise without fasting, and one will act as a control group. Throughout the study, measurements will be repeated, and data analysis will follow to evaluate results.http://www.sciencedirect.com/science/article/pii/S2451865421000673Intermittent fastingNutritionSports medicineAerobic exerciseExercise performanceHealth biomarkers |
spellingShingle | Abbass El-Outa Lara Ghandour Hani Hamade Cecile Borgi Elie-Jacques Fares Tarek Gherbal Afif Mufarrij Intermittent fasting & performance: The iFast clinical trial protocol Contemporary Clinical Trials Communications Intermittent fasting Nutrition Sports medicine Aerobic exercise Exercise performance Health biomarkers |
title | Intermittent fasting & performance: The iFast clinical trial protocol |
title_full | Intermittent fasting & performance: The iFast clinical trial protocol |
title_fullStr | Intermittent fasting & performance: The iFast clinical trial protocol |
title_full_unstemmed | Intermittent fasting & performance: The iFast clinical trial protocol |
title_short | Intermittent fasting & performance: The iFast clinical trial protocol |
title_sort | intermittent fasting amp performance the ifast clinical trial protocol |
topic | Intermittent fasting Nutrition Sports medicine Aerobic exercise Exercise performance Health biomarkers |
url | http://www.sciencedirect.com/science/article/pii/S2451865421000673 |
work_keys_str_mv | AT abbasselouta intermittentfastingampperformancetheifastclinicaltrialprotocol AT laraghandour intermittentfastingampperformancetheifastclinicaltrialprotocol AT hanihamade intermittentfastingampperformancetheifastclinicaltrialprotocol AT cecileborgi intermittentfastingampperformancetheifastclinicaltrialprotocol AT eliejacquesfares intermittentfastingampperformancetheifastclinicaltrialprotocol AT tarekgherbal intermittentfastingampperformancetheifastclinicaltrialprotocol AT afifmufarrij intermittentfastingampperformancetheifastclinicaltrialprotocol |